Barrett's esophagus: Treatments of adenocarcinomas II

William S. Twaddell; Peter C. Wu; Roy J.J. Verhage; Marcus Feith; David H. Ilson; Christoph P. Schuhmacher; James D. Luketich; Björn Brücher; Daniel Vallböhmer; Wayne L. Hofstetter; Mark Jonathan Krasna; Daniela Kandioler; Paul M. Schneider; Bas P.L. Wijnhoven; Stephen J. Sontag

doi:10.1111/j.1749-6632.2011.06056.x

Barrett's esophagus: Treatments of adenocarcinomas II

William S. Twaddell, Peter C. Wu, Roy J.J. Verhage, Marcus Feith, David H. Ilson, Christoph P. Schuhmacher, James D. Luketich, Björn Brücher, Daniel Vallböhmer, Wayne L. Hofstetter, Mark Jonathan Krasna, Daniela Kandioler, Paul M. Schneider, Bas P.L. Wijnhoven, Stephen J. Sontag

Default

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

The following topics are explored in this collection of commentaries on treatments of adenocarcinomas related to Barrett's esophagus: the importance of intraoperative frozen sections of the margins for the detection of high dysplasia; the preferable way for sentinel node dissection; the current role of robotic surgery and of video-endoscopic approach; the value of the Siewert's classification of adenocarcinomas; the indications of two-step esophagectomy; the evaluation of pathological complete response; the role of PET scan in staging and response assessment; the role of p53 in the selection of adenocarcinomas patients; chemotherapy regimens for adenocarcinomas; the use of monoclonal antibodies in the control of cell proliferation; he attempt to define a stage-specific strategy, and the possible indications of selective therapy; and changes in mortality rates from esophageal cancer.

Original language	English
Pages (from-to)	265-291
Number of pages	27
Journal	Annals of the New York Academy of Sciences
Volume	1232
Issue number	1
DOIs	https://doi.org/10.1111/j.1749-6632.2011.06056.x
State	Published - Sep 2011

Keywords

5-FU
AEG
Adenocarcinoma
Adenovirus vector
Barrett's esophagus
Chemoradiation
Chemoradiotherapy
Cisplatin
EGFR
Esophageal cancer
FDG PET scan
FOLFOX
Gamma probe
Gefitinib
HER2
High risk patients
Integrated PET/CT scan
Lymphadenectomy
Minimally invasive esophagectomy
Molecular markers
Multimodality therapy
Neoadjuvant chemotherapy
P53
PET tracer
Prognosis
R0 resection
Radiotherapy
Residual disease
Robot assisted thoracolaparoscopic esophagectomy
Robotic surgery
Sentinel lymph nodes
Sentinel node
Siewert 's classification
Submucosal invasion
Two-stade esophagectomy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/j.1749-6632.2011.06056.x

Cite this

Twaddell, W. S., Wu, P. C., Verhage, R. J. J., Feith, M., Ilson, D. H., Schuhmacher, C. P., Luketich, J. D., Brücher, B., Vallböhmer, D., Hofstetter, W. L., Krasna, M. J., Kandioler, D., Schneider, P. M., Wijnhoven, B. P. L., & Sontag, S. J. (2011). Barrett's esophagus: Treatments of adenocarcinomas II. Annals of the New York Academy of Sciences, 1232(1), 265-291. https://doi.org/10.1111/j.1749-6632.2011.06056.x

@article{ff5d2590f1794fa59c1f6b7324be67de,

title = "Barrett's esophagus: Treatments of adenocarcinomas II",

abstract = "The following topics are explored in this collection of commentaries on treatments of adenocarcinomas related to Barrett's esophagus: the importance of intraoperative frozen sections of the margins for the detection of high dysplasia; the preferable way for sentinel node dissection; the current role of robotic surgery and of video-endoscopic approach; the value of the Siewert's classification of adenocarcinomas; the indications of two-step esophagectomy; the evaluation of pathological complete response; the role of PET scan in staging and response assessment; the role of p53 in the selection of adenocarcinomas patients; chemotherapy regimens for adenocarcinomas; the use of monoclonal antibodies in the control of cell proliferation; he attempt to define a stage-specific strategy, and the possible indications of selective therapy; and changes in mortality rates from esophageal cancer.",

keywords = "5-FU, AEG, Adenocarcinoma, Adenovirus vector, Barrett's esophagus, Chemoradiation, Chemoradiotherapy, Cisplatin, EGFR, Esophageal cancer, FDG PET scan, FOLFOX, Gamma probe, Gefitinib, HER2, High risk patients, Integrated PET/CT scan, Lymphadenectomy, Minimally invasive esophagectomy, Molecular markers, Multimodality therapy, Neoadjuvant chemotherapy, P53, PET tracer, Prognosis, R0 resection, Radiotherapy, Residual disease, Robot assisted thoracolaparoscopic esophagectomy, Robotic surgery, Sentinel lymph nodes, Sentinel node, Siewert 's classification, Submucosal invasion, Two-stade esophagectomy",

author = "Twaddell, {William S.} and Wu, {Peter C.} and Verhage, {Roy J.J.} and Marcus Feith and Ilson, {David H.} and Schuhmacher, {Christoph P.} and Luketich, {James D.} and Bj{\"o}rn Br{\"u}cher and Daniel Vallb{\"o}hmer and Hofstetter, {Wayne L.} and Krasna, {Mark Jonathan} and Daniela Kandioler and Schneider, {Paul M.} and Wijnhoven, {Bas P.L.} and Sontag, {Stephen J.}",

year = "2011",

month = sep,

doi = "10.1111/j.1749-6632.2011.06056.x",

language = "English",

volume = "1232",

pages = "265--291",

journal = "Annals of the New York Academy of Sciences",

issn = "0077-8923",

publisher = "John Wiley and Sons Inc.",

number = "1",

}

Twaddell, WS, Wu, PC, Verhage, RJJ, Feith, M, Ilson, DH, Schuhmacher, CP, Luketich, JD, Brücher, B, Vallböhmer, D, Hofstetter, WL, Krasna, MJ, Kandioler, D, Schneider, PM, Wijnhoven, BPL & Sontag, SJ 2011, 'Barrett's esophagus: Treatments of adenocarcinomas II', Annals of the New York Academy of Sciences, vol. 1232, no. 1, pp. 265-291. https://doi.org/10.1111/j.1749-6632.2011.06056.x

TY - JOUR

T1 - Barrett's esophagus

T2 - Treatments of adenocarcinomas II

AU - Twaddell, William S.

AU - Wu, Peter C.

AU - Verhage, Roy J.J.

AU - Feith, Marcus

AU - Ilson, David H.

AU - Schuhmacher, Christoph P.

AU - Luketich, James D.

AU - Brücher, Björn

AU - Vallböhmer, Daniel

AU - Hofstetter, Wayne L.

AU - Krasna, Mark Jonathan

AU - Kandioler, Daniela

AU - Schneider, Paul M.

AU - Wijnhoven, Bas P.L.

AU - Sontag, Stephen J.

PY - 2011/9

Y1 - 2011/9

N2 - The following topics are explored in this collection of commentaries on treatments of adenocarcinomas related to Barrett's esophagus: the importance of intraoperative frozen sections of the margins for the detection of high dysplasia; the preferable way for sentinel node dissection; the current role of robotic surgery and of video-endoscopic approach; the value of the Siewert's classification of adenocarcinomas; the indications of two-step esophagectomy; the evaluation of pathological complete response; the role of PET scan in staging and response assessment; the role of p53 in the selection of adenocarcinomas patients; chemotherapy regimens for adenocarcinomas; the use of monoclonal antibodies in the control of cell proliferation; he attempt to define a stage-specific strategy, and the possible indications of selective therapy; and changes in mortality rates from esophageal cancer.

AB - The following topics are explored in this collection of commentaries on treatments of adenocarcinomas related to Barrett's esophagus: the importance of intraoperative frozen sections of the margins for the detection of high dysplasia; the preferable way for sentinel node dissection; the current role of robotic surgery and of video-endoscopic approach; the value of the Siewert's classification of adenocarcinomas; the indications of two-step esophagectomy; the evaluation of pathological complete response; the role of PET scan in staging and response assessment; the role of p53 in the selection of adenocarcinomas patients; chemotherapy regimens for adenocarcinomas; the use of monoclonal antibodies in the control of cell proliferation; he attempt to define a stage-specific strategy, and the possible indications of selective therapy; and changes in mortality rates from esophageal cancer.

KW - 5-FU

KW - AEG

KW - Adenocarcinoma

KW - Adenovirus vector

KW - Barrett's esophagus

KW - Chemoradiation

KW - Chemoradiotherapy

KW - Cisplatin

KW - EGFR

KW - Esophageal cancer

KW - FDG PET scan

KW - FOLFOX

KW - Gamma probe

KW - Gefitinib

KW - HER2

KW - High risk patients

KW - Integrated PET/CT scan

KW - Lymphadenectomy

KW - Minimally invasive esophagectomy

KW - Molecular markers

KW - Multimodality therapy

KW - Neoadjuvant chemotherapy

KW - P53

KW - PET tracer

KW - Prognosis

KW - R0 resection

KW - Radiotherapy

KW - Residual disease

KW - Robot assisted thoracolaparoscopic esophagectomy

KW - Robotic surgery

KW - Sentinel lymph nodes

KW - Sentinel node

KW - Siewert 's classification

KW - Submucosal invasion

KW - Two-stade esophagectomy

UR - http://www.scopus.com/inward/record.url?scp=80053207539&partnerID=8YFLogxK

U2 - 10.1111/j.1749-6632.2011.06056.x

DO - 10.1111/j.1749-6632.2011.06056.x

M3 - Article

AN - SCOPUS:80053207539

SN - 0077-8923

VL - 1232

SP - 265

EP - 291

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

IS - 1

ER -

Barrett's esophagus: Treatments of adenocarcinomas II

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this